Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2003 1
2004 1
2005 4
2006 4
2007 8
2008 7
2009 9
2010 2
2011 6
2012 7
2013 4
2014 5
2015 4
2016 8
2017 8
2018 12
2019 10
2020 12
2021 13
2022 5
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Epilepsy and cannabidiol: a guide to treatment.
Arzimanoglou A, Brandl U, Cross JH, Gil-Nagel A, Lagae L, Landmark CJ, Specchio N, Nabbout R, Thiele EA, Gubbay O, The Cannabinoids International Experts Panel; Collaborators. Arzimanoglou A, et al. Epileptic Disord. 2020 Feb 1;22(1):1-14. doi: 10.1684/epd.2020.1141. Epileptic Disord. 2020. PMID: 32096470 Free article. Review.
The growing interest in cannabidiol (CBD), specifically a pure form of CBD, as a treatment for epilepsy, among other conditions, is reflected in recent changes in legislation in some countries. ...However, just as we are beginning to understand the significance of CBD as a …
The growing interest in cannabidiol (CBD), specifically a pure form of CBD, as a treatment for epilepsy, among other conditions, is r …
Autoimmune seizures and epilepsy.
Geis C, Planagumà J, Carreño M, Graus F, Dalmau J. Geis C, et al. Among authors: carreno m. J Clin Invest. 2019 Mar 1;129(3):926-940. doi: 10.1172/JCI125178. Epub 2019 Feb 4. J Clin Invest. 2019. PMID: 30714986 Free PMC article. Review.
The rapid expansion in the number of encephalitis disorders associated with autoantibodies against neuronal proteins has led to an incremental increase in use of the term "autoimmune epilepsy," yet has occurred with limited attention to the physiopathology of each disease …
The rapid expansion in the number of encephalitis disorders associated with autoantibodies against neuronal proteins has led to an increment …
Classification of paroxysmal events and the four-dimensional epilepsy classification system.
Lüders H, Vaca GF, Akamatsu N, Amina S, Arzimanoglou A, Baumgartner C, Benbadis SR, Bleasel A, Bermeo-Ovalle A, Bozorgi A, Carreño M, Devereaux M, Francione S, Losarcos NG, Hamer H, Holthausen H, Jamal-Omidi S, Kalamangalam G, Kanner AM, Knake S, Lacuey N, Lhatoo S, Lim SH, Londoño LV, Mani J, Matsumoto R, Miller JP, Noachtar S, Palmini A, Park J, Rosenow F, Shahid A, Schuele S, Steinhoff BJ, Ákos Szabó C, Tandon N, Terada K, Boas WVE, Widdess-Walsh P, Kahane P. Lüders H, et al. Among authors: carreno m. Epileptic Disord. 2019 Feb 1;21(1):1-29. doi: 10.1684/epd.2019.1033. Epileptic Disord. 2019. PMID: 30782582 Review.
This educational review describes the classification of paroxysmal events and a four-dimensional epilepsy classification system. Paroxysmal events are classified as epileptic and non-epileptic paroxysmal events. ...The review also includes 12 educational vignettes and thre …
This educational review describes the classification of paroxysmal events and a four-dimensional epilepsy classification system. Paro …
Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies.
Serrano-Castro PJ, Rodríguez-Uranga JJ, Cabezudo-García P, García-Martín G, Romero-Godoy J, Estivill-Torrús G, Ciano-Petersen NL, Oliver B, Ortega-Pinazo J, López-Moreno Y, Aguilar-Castillo MJ, Gutierrez-Cardo AL, Ramírez-García T, Sanchez-Godoy L, Carreño M. Serrano-Castro PJ, et al. Among authors: carreno m. Neurol Neuroimmunol Neuroinflamm. 2023 Aug 22;10(6):e200151. doi: 10.1212/NXI.0000000000200151. Print 2023 Nov. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37607753 Free PMC article.
BACKGROUND AND OBJECTIVES: Autoimmune-associated epilepsy (AAE) with antiglutamic acid decarboxylase 65 (GAD65) antibodies is considered a T-cell-mediated encephalitis that evolves to drug-resistant epilepsy. ...METHODS: We recruit a retrospective multicentric conse …
BACKGROUND AND OBJECTIVES: Autoimmune-associated epilepsy (AAE) with antiglutamic acid decarboxylase 65 (GAD65) antibodies is conside …
Sleep-Related Epilepsy.
Carreño M, Fernández S. Carreño M, et al. Curr Treat Options Neurol. 2016 May;18(5):23. doi: 10.1007/s11940-016-0402-9. Curr Treat Options Neurol. 2016. PMID: 27059342 Review.
Interictal epileptiform discharges are activated by sleep deprivation and sleep, and some epilepsies occur almost exclusively during sleep. Treatment of sleep-related epilepsy should take in account the type of epileptic syndrome, the type of seizures, the patient c …
Interictal epileptiform discharges are activated by sleep deprivation and sleep, and some epilepsies occur almost exclusively during …
[PET and SPECT in epilepsy].
Setoain X, Carreño M, Pavía J, Martí-Fuster B, Campos F, Lomeña F. Setoain X, et al. Among authors: carreno m. Rev Esp Med Nucl Imagen Mol. 2014 May-Jun;33(3):165-74. doi: 10.1016/j.remn.2014.01.001. Epub 2014 Feb 22. Rev Esp Med Nucl Imagen Mol. 2014. PMID: 24565567 Review. Spanish.
Epilepsy is one of the most frequent chronic neurological disorders, affecting 1-2% of the population. ...Similarly, the injection methodology, quantification and evaluation of the images of the PET in epilepsy are described. Finally, the main clinical indications o …
Epilepsy is one of the most frequent chronic neurological disorders, affecting 1-2% of the population. ...Similarly, the injection me …
Seizures and epilepsy of autoimmune origin: A long-term prospective study.
Falip M, Jaraba S, Rodríguez-Bel L, Castañer S, Mora J, Arroyo P, Miro J, Sala-Padró J, Martínez-Yélamos S, Casasnovas C, Gascon-Bayarri J, Real E, Morandeira F, Vidal N, Veciana M, Saiz A, Carreño M. Falip M, et al. Among authors: carreno m. Seizure. 2020 Oct;81:157-165. doi: 10.1016/j.seizure.2020.07.019. Epub 2020 Jul 25. Seizure. 2020. PMID: 32818871 Free article.
OBJECTIVE: To follow prospectively a group of patients with seizures or epilepsy and suggestive clinical features of autoimmune aetiology and find out how many are finally diagnosed with acute symptomatic seizures (ASS) secondary to autoimmune encephalitis or autoimmune-re …
OBJECTIVE: To follow prospectively a group of patients with seizures or epilepsy and suggestive clinical features of autoimmune aetio …
Levetiracetam.
Carreno M. Carreno M. Drugs Today (Barc). 2007 Nov;43(11):769-94. doi: 10.1358/dot.2007.43.11.1136902. Drugs Today (Barc). 2007. PMID: 18174964 Review.
Its rapid onset of action, lack of drug-drug interactions and availability as an intravenous solution make it an optimal drug to treat epilepsy associated with other medical conditions. Preliminary reports also suggest potential efficacy in refractory status epilepticus, a …
Its rapid onset of action, lack of drug-drug interactions and availability as an intravenous solution make it an optimal drug to treat ep …
Surgery and electrical stimulation in epilepsy: selection of candidates and results.
Villanueva V, Carreño M, Herranz Fernández JL, Gil-Nagel A. Villanueva V, et al. Among authors: carreno m. Neurologist. 2007 Nov;13(6 Suppl 1):S29-37. doi: 10.1097/NRL.0b013e31815c0fbc. Neurologist. 2007. PMID: 18090949 Review.
BACKGROUND: Despite the correct use of antiepileptic drugs, control of seizures is not possible in 20% to 30% of people with epilepsy. This group of patients is considered to suffer from drug-resistant epilepsy, a clinical situation that can be caused by certain syn …
BACKGROUND: Despite the correct use of antiepileptic drugs, control of seizures is not possible in 20% to 30% of people with epilepsy …
Hypoglycemic seizures and epilepsy in type I diabetes mellitus.
Falip M, Miró J, Carreño M, Jaraba S, Becerra JL, Cayuela N, Perez Maraver M, Graus F. Falip M, et al. Among authors: carreno m. J Neurol Sci. 2014 Nov 15;346(1-2):307-9. doi: 10.1016/j.jns.2014.08.024. Epub 2014 Aug 27. J Neurol Sci. 2014. PMID: 25183236
PURPOSE: (1) To determine the characteristics of seizures and/or epilepsy among patients with adult onset type 1 diabetes mellitus (T1DM), and (2) to determine glutamic acid decarboxylase antibody (antiGADab) titres and other autoimmune characteristics of T1DM patients wit …
PURPOSE: (1) To determine the characteristics of seizures and/or epilepsy among patients with adult onset type 1 diabetes mellitus (T …
122 results